November 2, 2018 11:32 AM EDTUpdated 11:47 AM
Financing
Startups

Ome­icos scores $19.5M in Se­ries C to take its omega-3 drug to the next round

ENDPOINTS

Berlin-based Ome­icos Ther­a­peu­tics has closed €17 mil­lion in Se­ries C fi­nanc­ing, mon­ey the car­dio-and-eye fo­cused biotech says it’ll use to take its lead drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times